Fundraising FoxCatalytic Impact Foundation
FoundationPre-Seed–Series A
Find your way into Catalytic Impact Foundation
Sign up to find every way you can get introduced to Catalytic Impact Foundation
- Your email: who you already know at Catalytic Impact Foundation, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Catalytic Impact Foundation team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
CIF addresses unmet medical needs by bridging the funding gap for early-stage health and life science innovations struggling through the 'Valley of Death' toward commercialization. Launched in 2015 with founding donor Resonance Philanthropies, it deploys donated capital from family foundations and donor advised funds to make impact investments in promising companies tackling areas such as rare diseases, pediatric cancer, mental illness, and age-related care. Using an evergreen structure, returns are recycled back into the fund for further impact. CIF works through a community of expert leaders and partnerships with philanthropic, investment, research, and industry organizations to identify and accelerate the most innovative treatments from lab to patient.
Source: firm website, verified Oct 2, 2026.
What they invest in
from 3 of 4 portfolio companiesAI & Machine Learning ×3Biotech ×2Healthtech ×2Data & Infrastructure ×1Digital Health ×1Medical Devices ×1SaaS ×1
HQs:United States×2
Investments · 4 tracked
founders shown can be your intro path
CB Insights provides a market intelligence platform that offers verified data, analytics, and predictive scoring on over 12 million private and public companies.
AI & Machine LearningData & InfrastructureSaaS
Co-investorsAlumni VenturesBasecamp FundCartaCRV (Charles River Ventures)Essentia VenturesInCountry+7 more
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)in
BoardSurbhi Sarna(Director)in
Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+35 more
Stingray is an oncology-focused biotech company developing drugs from discovery through clinical development to commercialization, led by scientists and physicians with experience in building oncology companies.
AI & Machine LearningBiotechHealthtechHouston, US
Jonathan Northrup(Chief Executive Officer, Co-Founder)inSunil Sharma(Chief Medical Officer, Co-Founder)inScott Andrew Jordan(Executive Officer, Director, Promoter)
Co-investorsGreen Park & Golf Ventures
Frequently asked questions
- What stage does Catalytic Impact Foundation invest at?
- Catalytic Impact Foundation invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Catalytic Impact Foundation focus on?
- Catalytic Impact Foundation focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Longevity, Medical Devices, Mental Health.